Streetbeat News

Price Targets

BKNG

A large investor has taken a bullish stance on Booking Holdings (NASDAQ:BKNG), with Benzinga's options scanner spotting 16 uncommon options trades. The sentiment is split between 62% bullish and 37% bearish, with a price target range of $2500 to $3250 for Booking Holdings over the last 3 months.

Portfolio Pulse from Benzinga Insights

June 06, 2023 | 2:03 pm

SYNA

In the last 3 months, 12 analysts have offered 12-month price targets for Synaptics (NASDAQ:SYNA), with an average price target of $117.5, a 20.46% decrease from the previous average price target of $147.73. The ratings include 5 bullish, 4 somewhat bullish, and 3 indifferent.

Portfolio Pulse from Benzinga Insights

June 06, 2023 | 2:01 pm

CMPS

HC Wainwright & Co. analyst Patrick Trucchio reiterated a Buy rating on Compass Pathways (NASDAQ:CMPS) and maintained a $120 price target.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 1:59 pm

MBOT

HC Wainwright & Co. analyst Raghuram Selvaraju reiterated a Buy rating on Microbot Medical (NASDAQ:MBOT) and maintained an $8 price target.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 1:55 pm

STTK

Needham analyst Gil Blum reiterated a Buy rating on Shattuck Labs (NASDAQ:STTK) and maintained a $14 price target.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 1:51 pm

LEGN

HC Wainwright raised its price target on Legend Biotech (LEGN) shares from $77 to $82, causing the stock to trade higher.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 1:50 pm

GTLB

Scotiabank analyst Nick Altmann maintains a Sector Outperform rating on GitLab (NASDAQ:GTLB) and raises the price target from $36 to $50.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 1:43 pm

CHS

Telsey Advisory Group analyst Dana Telsey has reiterated a Market Perform rating on Chico's FAS (NYSE:CHS) and maintained a $6 price target.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 1:41 pm

HQY

RBC Capital analyst Sean Dodge has reiterated an Outperform rating on HealthEquity (NASDAQ:HQY) and maintained a $75 price target.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 1:31 pm

NVRO

RBC Capital analyst Shagun Singh reiterated an Outperform rating on Nevro (NYSE:NVRO) and maintained a $40 price target.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 1:28 pm